NRx Pharmaceuticals, Inc.
NRXP
$2.27
-$0.02-0.87%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -68.60% | -81.51% | -87.32% | -92.01% | -77.09% |
| Total Receivables | -- | 0.00% | 0.00% | 0.00% | -14.29% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 104.96% | -26.40% | -23.22% | -46.21% | -62.53% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -5.40% | -57.58% | -58.87% | -70.77% | -55.70% |
| Total Current Assets | -52.03% | -68.63% | -75.34% | -84.62% | -73.31% |
|
|
|||||
| Total Current Assets | -52.03% | -68.63% | -75.34% | -84.62% | -73.31% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -19.03% | 1,595.24% | 1,728.57% | 1,737.50% | 1,952.38% |
| Total Assets | -50.09% | -65.96% | -73.43% | -82.61% | -71.66% |
|
|
|||||
| Total Accounts Payable | -10.84% | 34.01% | 127.44% | 65.92% | 123.12% |
| Total Accrued Expenses | 224.19% | 8.73% | 3.73% | -4.73% | -9.20% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -86.40% | -69.71% | -39.72% | -44.38% | 18.93% |
| Total Finance Division Other Current Liabilities | 93,976.47% | 1,942.28% | 366.42% | 4.00% | -54.05% |
| Total Other Current Liabilities | 93,976.47% | 1,942.28% | 366.42% | 4.00% | -54.05% |
| Total Current Liabilities | 14.78% | 5.03% | 4.59% | -14.53% | 22.22% |
|
|
|||||
| Total Current Liabilities | 14.78% | 5.03% | 4.59% | -14.53% | 22.22% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 41.09% | 20.47% | 4.59% | -14.53% | 3.48% |
|
|
|||||
| Common Stock & APIC | 5.65% | 3.20% | 3.84% | 4.69% | 4.78% |
| Retained Earnings | -9.93% | -8.19% | -10.22% | -10.96% | -13.52% |
| Treasury Stock & Other | -- | -- | 86.36% | -102.83% | -- |
| Total Common Equity | -97.88% | -202.60% | -554.95% | -5,205.99% | -258.40% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -97.88% | -202.60% | -554.95% | -5,205.99% | -258.40% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -97.93% | -202.75% | -554.95% | -5,205.99% | -258.36% |
|
|
|||||